Neutralization sensitivity of cell culture passaged simian immunodeficiency virus

被引:140
作者
Means, RE
Greenough, T
Desrosiers, RC
机构
[1] HARVARD UNIV, NEW ENGLAND REG PRIMATE RES CTR, SCH MED, SOUTHBOROUGH, MA 01772 USA
[2] UNIV MASSACHUSETTS, SCH MED, DEPT PEDIAT, PROGRAM MOL MED, WORCESTER, MA 01605 USA
关键词
D O I
10.1128/JVI.71.10.7895-7902.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CEMx174- and C8166-45-based cell lines which contain a secreted alkaline phosphatase (SEAP) reporter gene under the control of a tat-responsive promoter derived from either SIVmac239 or HIV-1(NL4-3) were constructed. Basal levels of SEAP activity from these cell lines were low but were greatly stimulated upon transfection of tat expression plasmids. Infection of these cell lines with simian immunodeficiency virus (SIS? or human immunodeficiency virus type 1 (HIV-1) resulted in a dramatic increase in SEAP production within 48 to 72 h that directly correlated with the amount of infecting virus. When combined,vith chemiluminescent measurement of SEAP activity in the cell-free supernatant, these cells formed the basis of a rapid, sensitive, and quantitative assay for SIV and HIV infectivity and neutralization. Eight of eight primary isolates of HIV-I that were tested induced readily measurable SEAP activity in this system. While serum neutralization of cloned STVmac239 was difficult to detect with other assays, neutralization of SIVmac239 was readily detected at low titers with this new assay system. The neutralization sensitivities of two stocks of SIVmac251 with different cell culture passage histories were tested by using sera from SIV-infected monkeys. The primary stock of SIVmac251 had been passaged only twice through primary cultures of rhesus monkey peripheral blood mononuclear cells, while the laboratory-adapted stock had been extensively passaged through the MT4 immortalized T-cell line. The primary stock of SIVmac251 was much more resistant to neutralization by a battery of poly clonal sera from SIV-infected monkeys than was the laboratory-adapted virus. Thus, SIVmac appears to be similar to HIV-1 in that extensive laboratory passage through T-cell lines resulted in a virus that is much more sensitive to serum neutralization.
引用
收藏
页码:7895 / 7902
页数:8
相关论文
共 68 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   NEUTRALIZING CROSS-REACTIVE AND NONNEUTRALIZING MONOCLONAL-ANTIBODIES TO HIV-1 GP120 [J].
AKERBLOM, L ;
HINKULA, J ;
BROLIDEN, PA ;
MAKITALO, B ;
FRIDBERGER, T ;
ROSEN, J ;
VILLACRESERIKSSON, M ;
MOREIN, B ;
WAHREN, B .
AIDS, 1990, 4 (10) :953-960
[3]   RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA [J].
ALBERT, J ;
ABRAHAMSSON, B ;
NAGY, K ;
AURELIUS, E ;
GAINES, H ;
NYSTROM, G ;
FENYO, EM .
AIDS, 1990, 4 (02) :107-112
[4]   ANTIGEN-DETECTION IS A RELIABLE METHOD FOR EVALUATING HIV SIV NEUTRALIZATION ASSAYS [J].
ALBERT, J ;
BJORLING, E ;
VONGEGERFELT, A ;
SCARLATTI, G ;
ZHANG, YJ ;
FENYO, EM ;
THORSTENSSON, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (06) :501-504
[5]   IDENTIFICATION OF A NEUTRALIZING DOMAIN IN THE EXTERNAL ENVELOPE GLYCOPROTEIN OF SIMIAN IMMUNODEFICIENCY VIRUS [J].
BENICHOU, S ;
LEGRAND, R ;
NAKAGAWA, N ;
FAURE, T ;
TRAINCARD, F ;
VOGT, G ;
DORMONT, D ;
TIOLLAIS, P ;
KIENY, MP ;
MADAULE, P .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (06) :1165-1170
[6]   SECRETED PLACENTAL ALKALINE-PHOSPHATASE - A POWERFUL NEW QUANTITATIVE INDICATOR OF GENE-EXPRESSION IN EUKARYOTIC CELLS [J].
BERGER, J ;
HAUBER, J ;
HAUBER, R ;
GEIGER, R ;
CULLEN, BR .
GENE, 1988, 66 (01) :1-10
[7]   A PREDOMINANT GROUP-SPECIFIC NEUTRALIZING EPITOPE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MAPS TO RESIDUE-342 TO RESIDUE-511 OF THE ENVELOPE GLYCOPROTEIN-GP120 [J].
BERKOWER, I ;
MURPHY, D ;
SMITH, CC ;
SMITH, GE .
JOURNAL OF VIROLOGY, 1991, 65 (11) :5983-5990
[8]   AUTOLOGOUS NEUTRALIZING ANTIBODIES PREVAIL IN HIV-2 BUT NOT IN HIV-1 INFECTION [J].
BJORLING, E ;
SCARLATTI, G ;
VONGEGERFELT, A ;
ALBERT, J ;
BIBERFELD, G ;
CHIODI, F ;
NORRBY, E ;
FENYO, EM .
VIROLOGY, 1993, 193 (01) :528-530
[9]   HYPERIMMUNE ANTISERA AGAINST SYNTHETIC PEPTIDES REPRESENTING THE GLYCOPROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 CAN MEDIATE NEUTRALIZATION AND ANTIBODY-DEPENDENT CYTOTOXIC ACTIVITY [J].
BJORLING, E ;
BROLIDEN, K ;
BERNARDI, D ;
UTTER, G ;
THORSTENSSON, R ;
CHIODI, F ;
NORRBY, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6082-6086
[10]   INVIVO GENETIC-VARIABILITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 V3-REGION [J].
BOERI, E ;
GIRI, A ;
LILLO, F ;
FERRARI, G ;
VARNIER, OE ;
FERRO, A ;
SABBATANI, S ;
SAXINGER, WC ;
FRANCHINI, G .
JOURNAL OF VIROLOGY, 1992, 66 (07) :4546-4550